SEP 30, 2024·BEHAVIORAL HEALTH BUSINESSNEWS
‘Setting a Precedent’: Cognoa Earns Medicaid Coverage for Early-Autism Diagnosis Tool§01 · Overview
About Cognoa.
FDA-authorized AI-powered autism diagnostic and developmental monitoring platform.
§04 · Product details
What Cognoa costs.
Pricing, deployment and integrations are self-reported by the vendor and re-attested each time the profile is updated.
- Deployment
- CloudWhere the product runs
- Free tier
- NoNo free plan
- Pricing notes
- Cognoa's Canvas Dx is an FDA-cleared Software as a Medical Device (SaMD) for autism diagnosis. It is prescribed by providers and covered by insurers (e.g., Highmark, Wyoming Medicaid). No public list pricing found on cognoa.com; costs are billed through insurance/payer contracts.
§06 · Reviews
No published reviews yet.
Every reviewer's identity and engagement are verified by work-email cross-check before publication. Reviews cannot be edited or removed by the firm.
No reviews have been published for Cognoa yet. Be the first to review →
§07 · Around the web
2 Google reviews · 4.0 avg.
Aggregate rating and the most recent reviews from Google Maps. Reviews are written by the public and are not verified by Cognoa or this directory.
No individual reviews were returned by Google for Cognoa. The aggregate rating above reflects 2 public reviews on Google Maps.
Reviews powered by Google. Cached and refreshed within Google's 30-day window.
§07 · Verification
What we checked.
What we couldn't.
Every check is dated and re-runnable. If you can't reproduce the result with the source we cite, file a correction.
Verified Client Reviews
0
Overall Review Rating
—
Last Updated
—
OWNR
Ownership claim
No representative has claimed this profile yet.
PENDINGSITE
Website on file
https://www.cognoa.com
VERIFIED§09 · News
What the press is saying.
Third-party coverage of Cognoa, automatically discovered and filtered for relevance. We don't edit it. Click through to read the source.
SEP 27, 2024·MEDICAL DEVICE NETWORKNEWS
Cognoa’s AI child autism diagnostic gains Medicaid coverage in WyomingJAN 26, 2024·FIERCE HEALTHCARENEWS
Cognoa's FDA-approved autism diagnostic tool now in network for Highmark membersDEC 2, 2023·MEDICAL DEVICE AND DIAGNOSTIC INDUSTRYNEWS
Cognoa Makes Push to Get FDA Nod for Digital Autism DiagnosticJUN 3, 2021·MEDTECH DIVENEWS
Cognoa’s machine learning software for autism diagnosis gets FDA nodJUN 3, 2021·MEDICAL DEVICE NETWORKNEWS
Cognoa’s AI-based autism diagnosis aid gets FDA de novo clearanceJUN 2, 2021·FIERCE BIOTECHNEWS
Cognoa's AI app for diagnosing childhood autism gets FDA green lightAPR 6, 2021·BEHAVIORAL HEALTH BUSINESSNEWS
How Cognoa Aims to Revolutionize the Autism Diagnosis ProcessSEP 23, 2020·UNITE.AINEWS
Cognoa Seeks FDA Clearance for Digital Autism Diagnostic Device After Successful StudySEP 23, 2020·FIERCE BIOTECHNEWS
Cognoa's AI-powered diagnostic app for autism clears clinical study, heads for FDA review§08 · Contact
Reach out to Cognoa.
Inquiries route directly to the firm. ABA Rank does not broker introductions, take referral fees, or sell inquiry data.
UnclaimedIf you work at Cognoa, you can claim this profile.Claim profile →
ABA Rank has no contact address on file for Cognoa, so a message sent here would have nowhere to go. Use the website link to reach them directly.
Evaluating Cognoa? See the top Cognoa alternatives →